• Quarterly performance drivers: Top-line revenue increased by 13.5% and adjusted EBITDA grew about 20%, supported by a 17% growth in the non-institutional business, operating leverage, and lower interest costs.
• North Bengaluru facility: Quarterly losses peaked at ₹7 crore, with the new hospital targeted to achieve monthly operational break-even within 12 to 14 months of launch (early next year) as insurance empanelments and clinical programs ramp up.
• Margin expansion levers: Management targets EBITDA margins of 21%–22% in two years and 25% in four to five years by activating unused capacity across its 2,800-bed network, adopting advanced clinical technologies, and pursuing selective inorganic expansion.
• Regional cluster growth: The East cluster grew 22% due to robust demand in an underserved market, whereas the West cluster grew 9% because a strong 14%–14.5% expansion in Maharashtra was offset by a deliberate curtailment of low-margin business in Gujarat.